TAIPEI, Taiwan--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug development company, has agreed to license an approved Potassium Chloride Extended ...

LAKE FOREST, Ill., Feb. 13, 2025 /PRNewswire/ -- ICU Medical, Inc. is voluntarily recalling one lot each of POTASSIUM CHLORIDE Inj. bags with overwrap labels 10 mEq, packaged in cases of ...

Glenmark Pharmaceuticals Inc., based in Mahwah, NJ, has announced a voluntary recall of 114 batches of its Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K. The recall is ...

the FDA explained that Glenmark Pharmaceuticals Inc. is recalling 114 batches of a product called Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K. The reason is because of ...

(RTTNews) - The US Food and Drug Administration has annuonced that ICU Medical, Inc. is recalling Potassium Chloride Injection, 20 mEq and 10 mEq, citing mislabeling. The recall involves one lot ...

20 mEq bags due to incorrect overwrap labels, which state Potassium Chloride Inj. 10 mEq. Potassium Chloride Injection is indicated for the treatment of potassium deficiency, when oral replacement ...

packaged in cases of POTASSIUM CHLORIDE Inj. 20 mEq, to the user level. ICU medical has received a customer complaint which states that bags of POTASSIUM CHLORIDE Inj. 20 mEq have inco ...